Skip to main content

Table 4 Cardiac function and left atrial size from Motion (M)-mode parameters of myxomatous mitral valve degenerative dogs pre- and post-treatment in the control and treatment groups

From: Short-term melatonin supplementation decreases oxidative stress but does not affect left ventricular structure and function in myxomatous mitral valve degenerative dogs

Parameter

Control group (n = 11)

Treatment group (n = 18)

Pre-treatment

Post-treatment

Pre-treatment

Post-treatment

LA:AO ratio

1.61 ± 0.16

1.64 ± 0.16

1.79 ± 0.28

1.64 ± 0.16

EDV (mL)

24.94 ± 11.33

28.47 ± 13.55

28.80 ± 12.60

28.47 ± 13.55

EF (%)

71.83 ± 17.29

80.94 ± 8.57

80.54 ± 10.71

80.94 ± 8.57

ESV (mL)

6.96 ± 4.41

5.67 ± 4.25

5.07 ± 3.63

5.67 ± 4.25

FS (%)

41.82 ± 13.27

44.13 ± 18.43

49.89 ± 8.82

48.68 ± 10.26

SV (mL)

17.98 ± 8.81

20.73 ± 12.48

22.41 ± 12.25

22.80 ± 10.98

  1. Values are presented as mean ± SD. LA:AO left atrial on aortic, EDV end-diastolic volume, %EF % ejection fraction, ESV end-systolic volume, %FS % fractional shortening, SV stroke volume
Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us